GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Jul 2016 05:37 PM
RNS
Director/PDMR Shareholding
12 Jul 2016 05:34 PM
RNS
Director/PDMR Shareholding
12 Jul 2016 05:32 PM
RNS
Director/PDMR Shareholding
12 Jul 2016 05:19 PM
RNS
Director/PDMR Shareholding
12 Jul 2016 05:10 PM
RNS
Director/PDMR Shareholding
01 Jul 2016 04:25 PM
RNS
Director/PDMR Shareholding
01 Jul 2016 11:32 AM
RNS
Total Voting Rights
20 Jun 2016 07:02 AM
RNS
FULFIL Study Results Closed Triple EU
14 Jun 2016 10:58 AM
RNS
Directorate Change
10 Jun 2016 05:09 PM
RNS
Director/PDMR Shareholding
10 Jun 2016 04:48 PM
RNS
Director/PDMR Shareholding
08 Jun 2016 12:00 PM
RNS
Phase III Study of Sirukumab Results
02 Jun 2016 07:00 AM
RNS
Closed Triple Combined FF-UMEC-VI US Filing Plans
01 Jun 2016 09:55 AM
RNS
Total Voting Rights
27 May 2016 03:46 PM
RNS
Strimvelis receives EC marketing authorisation
27 May 2016 02:56 PM
RNS
Board and Committee changes
24 May 2016 10:54 AM
RNS
Salford Lung Study Results
23 May 2016 03:47 PM
RNS
Director/PDMR Shareholding
13 May 2016 10:56 AM
RNS
Director/PDMR Shareholding
12 May 2016 04:52 PM
RNS
Director/PDMR Shareholding
11 May 2016 11:48 AM
RNS
Block listing Interim Review
10 May 2016 05:15 PM
RNS
Director/PDMR Shareholding
09 May 2016 01:05 PM
RNS
Director/PDMR Shareholding
06 May 2016 01:30 PM
RNS
Director/PDMR Shareholding
05 May 2016 05:41 PM
RNS
Result of AGM
04 May 2016 02:55 PM
RNS
Director/PDMR Shareholding
04 May 2016 02:51 PM
RNS
Director/PDMR Shareholding
04 May 2016 02:44 PM
RNS
Director/PDMR Shareholding
03 May 2016 02:36 PM
RNS
Director/PDMR Shareholding
03 May 2016 11:28 AM
RNS
Director/PDMR Shareholding
03 May 2016 11:21 AM
RNS
Total Voting Rights
29 Apr 2016 05:47 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:43 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:34 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:29 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:23 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:19 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:14 PM
RNS
Director/PDMR Shareholding
29 Apr 2016 05:09 PM
RNS
Director/PDMR Shareholding
28 Apr 2016 12:43 PM
RNS
Director/PDMR Shareholding
27 Apr 2016 12:00 PM
RNS
1st Quarter Results
18 Apr 2016 05:09 PM
RNS
Director/PDMR Shareholding
18 Apr 2016 04:23 PM
RNS
Director/PDMR Shareholding
18 Apr 2016 04:16 PM
RNS
Director/PDMR Shareholding
15 Apr 2016 04:26 PM
RNS
Director/PDMR Shareholding
12 Apr 2016 06:07 PM
RNS
Director/PDMR Shareholding
11 Apr 2016 04:28 PM
RNS
Director/PDMR Shareholding
01 Apr 2016 03:33 PM
RNS
Director/PDMR Shareholding
01 Apr 2016 03:19 PM
RNS
Director/PDMR Shareholding
01 Apr 2016 03:07 PM
RNS
GSK receives positive CHMP opinion for Strimvelis

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings